Presentation of the report
This report has been prepared in accordance with the Norwegian Transparency Act (the “Transparency Act”) section 5 and summarizes the policies and procedures in Nattopharma AS (“Nattopharma”) with respect to safeguarding of human rights and decent working conditions and provides information on the imolementation and results of NattoPharma’s due diligence.
View the 2022 Transparency Act Report
Latest news & videos
- MenaQ7®
- Mobility & Joint
- Mythocondro®
- Mar 17, 2025
Exciting Insights into Longevity:
Vital Nutrients Symposium 2025 Is Just Around the Corner
The countdown has begun for the Vital Nutrients Symposium 2025, which will take place...
- Emothion®
- News
- Wellness & Immune
- Mar 12, 2025
Safety of S-Acetyl Glutathione confirmed for food and dietary supplements
Celebrating a new milestone: Safety assessment of S-Acetyl Glutathione for food and dietary supplement...
- News
- Quatrefolic®
- Reproduction & Women
- Mar 10, 2025
The Role of Bioavailability in Improving Health Benefits
In the fast-growing dietary supplement industry, innovation goes beyond new products to focus on...
